"doe-COE-sah-noll"
Abreva
Docosanol is used to treat "cold sores/fever blisters" (herpes labialis). It can speed up healing of the sores and decrease symptoms (such as tingling, pain, burning, itching). It works by blocking the virus that causes the cold sores (herpes simplex) from entering the healthy skin cells and growing in number. This medication does not cure herpes and does not prevent passing the infection to someone else. It does not prevent a future occurrence.
Do not use this medication to treat canker sores (sores found commonly in the mouth), shingles, or genital herpes.
Follow all directions on the product package, or use as directed by your doctor. Use this medication at the first signs of a cold sore (such as tingling, burning, redness, or a bump). Wash and dry your hands before applying the medication. Clean and dry the affected areas. Apply a thin layer of medication to completely cover the area of the cold sore or the area of tingling/itching/redness/swelling and rub in gently, usually 5 times a day every 3-4 hours, or as directed by your doctor. Wash your hands with soap and water after applying. If you have any questions, ask your doctor or pharmacist.
Apply to skin only. Do not apply this medication in or near the eyes since this medication can irritate the eyes. If you do get medication in your eyes, flush with plenty of water. Do not apply inside the mouth or nose.
Remove any cosmetics from the affected area before applying. You may apply cosmetics after applying but use a separate applicator (such as a disposable cotton swab) on infected areas to prevent spreading the infection. If you accidentally wipe off the medication, reapply as soon as possible.
Dosage is based on your medical condition, type of infection, and response to treatment. Do not use this drug more often or for longer than directed.
Use this medication regularly to get the most benefit from it. This medication works best when the amount of drug absorbed by the skin stays at a constant level. Use this drug at evenly spaced intervals. To help you remember, use it at the same times each day.
Cold sores (herpes) can spread easily. Docosanol does not prevent the spread of herpes. Avoid close physical contact with others (such as kissing) during an outbreak until the cold sores have completely healed. Also, try not to touch the cold sore, and wash your hands if you do touch the cold sore.
Stop using this medication and tell your doctor if your cold sores get worse or last for more than 10 days.
Copyright © 2024 TraceGains, Inc. All rights reserved.
RxAnswers™ is a copyrighted combined product from TraceGains and First DataBank, Inc.
Drug information is selected from data included with permission and copyrighted by First DataBank, Inc. This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional. Always seek the advice of your healthcare professional if you have any questions about this product or your medical condition. This information is not intended as individual medical advice and does not substitute for the knowledge and judgment of your healthcare professional. This information does not contain any assurances that this product is safe, effective or appropriate for you.
This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.
Learn more about First DataBank
There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.
Learn more about TraceGains, the company.
TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.
Information expires December 2024.